MAUDE Adverse Event Report: HOYA SURGICAL OPTICS, INC. 251; INTRAOCULAR LENS

Model Number	251 (+ 18 D)
Medical Device Problem Code	Sharp Edges (4013)
Health Effect - Clinical Code	Capsular Bag Tear (2639)
Date of Event	01/15/2026
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
This initial emdr is being submitted to the fda for a reportable event that occurred outside the usa.Posterior capsule rupture is indicated as a potential adverse event related to iol implantation, as stated under the warnings section of the product's instructions for use (ifu).Regarding section h6 - manufacturer's codes for: type of investigation, findings, and conclusion are pending completion of product investigation.Once the product investigation is completed, a follow-up report will be submitted to fda which will include the manufacturer's codes for type of investigation, findings, and conclusion.
Event or Problem Description
Event occurred in china.Leading haptic reported.Capsular bag tear rupture.The patient underwent phacoemulsification and intraocular lens implantation under topical anesthesia on (b)(6) 2026.During the implantation, the leading haptic of the intraocular lens tore the posterior capsule while unfolding.After adjusting the position of the intraocular lens and instilling carbachol to constrict the pupil, the iol was centered in the capsular bag.The surgery was completed smoothly with no adverse effects.Please refer to the attachment surgical picture.Problem code: a051102 - sharp edges.
Additional Manufacturer Narrative
This follow-up report # 1 emdr is being submitted to fda for a reportable event that occurred outside the usa.The report includes corrected and additional information not available/included in the initial report.Corrected information: h6 - updated codes for manufacturer's investigation: type; findings; and conclusion.Additional information: g6 - type of report - noted as follow-up #1.H2 - type of follow-up - noted for additional information.The product was not returned to the manufacturer.The investigation was conducted, with the methods and results as noted below.No abnormalities were found in production and inspection records of the product (serial no.: (b)(6); model: 251).The exact root cause was not determined.However, based on the available information and our investigation, we believe this event was not caused by our product quality.A review of the most recent complaint trending data indicates that no significant trends have been identified at this time and no capa is required as part of the product evaluation.

• Brand Name: 251
• Common Device Name: INTRAOCULAR LENS
• Manufacturer (Section D): HOYA SURGICAL OPTICS, INC.; 110 progress; suite 175; irvine CA 92618
• Manufacturer (Section G): HOYA MEDICAL SINGAPORE PTE LTD; 455a jalan ahmad ibrahim; singapore, singapore 63993 9; SN 639939
• Manufacturer Contact: ana paula lebkuchen geraldo ; 110 progress; suite 175; irvine, CA 92618
• MDR Report Key: 24318964
• Report Number: 3006723646-2026-00008
• Device Sequence Number: 13300433
• Product Code: HQL
• UDI-Device Identifier: 04547480450254
• UDI-Public: 04547480450254
• Combination Product (Y/N): N
• Initial Reporter Country: CH
• PMA/510(K) Number: P080004
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2026
• Serviced by Third Party (Y/N): Unknown
• Reporter Type: Manufacturer
• Report Source: Foreign,User Facility,Company Representative
• Initial Reporter Occupation: Other
• Type of Report: Initial,Followup
• Report Date (Section B): 02/01/2026

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Model Number: 251 (+ 18 D)
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: No
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 02/01/2026
• Supplement Date Received by Manufacturer: Not provided
• Initial Report FDA Received Date: 02/11/2026
• Supplement Report FDA Received Date: 03/04/2026
• Was Device Evaluated by Manufacturer? (Y/N): No
• Date Device Manufactured: 01/31/2025
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Sex: Unknown